Fred Middleton - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Fred Middleton’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Health Care,
- Wellness,
- Women Founded,
- Fundraising,
- Investment Management,
- Life Science,
- Portfolio Management,
- Information Technology (IT),
- Strategic Planning,
- Venture Fundraising,
- Finance,
- Biotechnology,
- Medical Devices,
- Innovation,
- Consulting,
- Digital Health,
- Information Technology,
- B2B,
- Healthcare Technology
Social media:
Past investments:
- Chimerix
- Taligen Therapeutics
- Vical
- CalciMedica
- SpecificiT Pharma
- Genteric
- NovoStent Corporation
- Pacira Pharmaceuticals, Inc.
- Naviscan
- Sotera Wireless
- Asteres
- Aderis Pharmaceuticals
- Kadmus Pharmaceuticals
- Alteer
- CyThera
- CoMentis
- Xytis
- Actimis/Axikin
- Tomophase
- Zapaq
- ViaCyte
- CardioNet
- Regeneron Pharmaceuticals
- PreciThera
- Ista Pharmaceuticals
- Sanderling Ventures (Biomedical Venture Capital)
- Endocyte
- Cylene Pharmaceuticals
- Metavention
- Lineagen
- Torax Medical
- DalCor Pharmaceuticals
- ViaCyte Inc.
- Altor Bioscience Corporation
- Lineagen, Inc.
- Dynavax Technologies
- Neomend
- Axikin Pharmaceuticals
- TheraVida
- Artielle ImmunoTherapeutics
- Net32
- InfraReDx
- Glycomine
- Stereotaxis
- BioTelemetry, Inc.
- Altor BioScience
- Gemin X Pharmaceuticals
- Trinity Biosystems
- Actimis Pharmaceuticals
Investor Profile
Fred Middleton is a Venture Capital, Private Equity Firm, Micro VC based in Burlingame, California, United States with a diverse investment portfolio that includes companies such as Chimerix, Taligen Therapeutics, Vical, CalciMedica, SpecificiT Pharma, Genteric, NovoStent Corporation, Pacira Pharmaceuticals, Inc., Naviscan, Sotera Wireless, Asteres, Aderis Pharmaceuticals, Kadmus Pharmaceuticals, Alteer, CyThera, CoMentis, XytisActimis/Axikin, Tomophase, Zapaq, ViaCyte, CardioNet, Regeneron Pharmaceuticals, PreciThera, Ista Pharmaceuticals, Sanderling Ventures (Biomedical Venture Capital), Endocyte, Cylene Pharmaceuticals, Metavention, Lineagen, Torax Medical, DalCor Pharmaceuticals, ViaCyte Inc., Altor Bioscience Corporation, Lineagen, Inc., Dynavax Technologies, Neomend, Axikin Pharmaceuticals, TheraVida, Artielle ImmunoTherapeutics, Net32, InfraReDx, Glycomine, Stereotaxis, BioTelemetry, Inc., Altor BioScience, Gemin X Pharmaceuticals, Trinity Biosystems, Actimis Pharmaceuticals, . Over time, Fred Middleton has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Fred Middleton is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Women Founded, Fundraising, Investment Management, Life Science, Portfolio Management, Information Technology (IT), Strategic Planning, Venture Fundraising, Finance, Biotechnology, Medical Devices, Innovation, Consulting, Digital Health, Information Technology, B2B, Healthcare Technology may find it worthwhile to explore potential connections with Fred Middleton, as their portfolio suggests a familiarity and interest in this area.
Understanding Fred Middleton’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
